Gara et al. (2015) describe the gene variant G534E in HABP2, which maps to chromosome 10q25.3, the overexpression of which can be detected in tumor cells from patients with FNMTC, relative to cells from the healthy regions of the thyroid gland, or patients with sporadic NMTC [36]. This evidence concerns the gene HABP2 and familial papillary or follicular thyroid carcinoma.